If you or a loved one has been injured by a transvaginal mesh implant,contact Cannon & Dunphy S.C. today for a free confidential consultation with the women on our staff.
Transvaginal mesh implants were one of many methods used to treat:
These conditions occur when the muscles and ligaments supporting a woman’s pelvic organs (bladder, rectum, uterus, vaginal canal and bowel) weaken. This weakening results in stress urinary incontinence (leaking urine with sneezing, laughing, running, etc.) and organs slipping out of place.
The symptoms of these conditions include:
Transvaginal mesh implants were originally cleared for marketing by the FDA in 2002; however, many gynecologic surgeons believed that the use of these mesh like products to hold the prolapsed organs in place was controversial from the outset. There were little to no studies done on transvaginal mesh implants before manufacturers began marketing them for use.
These manufacturers include:
From 2005-2010, the FDA received 3,785 reports of injuries from transvaginal mesh implants. These injuries included:
On July 13, 2011, the FDA issued a statement that serious complications are not rare with the use of transvaginal mesh. This statement was based on a review of literature from 1996-2011 that concluded that transvaginal mesh does not improve symptoms or quality of life more than non-mesh repair. Not surprisingly, a 2011 study published in the Journal of Obstetrics and Gynecology stated, “Until adequate effectiveness and safety evidence is available, the use of new transvaginal mesh devices for prolapse repair should be considered experimental and restricted to use in investigative trials.”
If you or a loved one has been injured by a transvaginal mesh implant, contact Cannon & Dunphy S.C. today for a free confidential consultation with the women on our staff.